Home/ Supplements/ Dim/ Prostate

Prostate

product on market Capsule Core Nutritionals Lifeline Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 44% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains saw palmetto, stinging nettle, and pumpkin seed oil, which have moderate evidence for supporting urinary function in men. DIM and flaxseed extract are included for hormonal balance, though clinical evidence for prostate-specific benefits is more limited. The ingredient profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Prostate
Open Full PDF View on NIH DSLD →
Details

Label Data

5 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
44%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Pumpkin Seed Oil, Powder
1000 mg
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)
Stinging Nettle extract
360 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
Market median: 200.0mg (3 products) 11 studies (A:1, B:3)
Pygeum africanum Bark Extract
200 mg
Beta-Sitosterol
180 mg
30 mg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)
6 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews

Other Ingredients

Cellulose Rice Flour Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 5 capsules daily with or without food.

Warnings & Precautions

Warning: This product is only intended for use in healthy adults 18 years of age or older.

Pregnant or nursing women should not use this product. Consult your healthcare provider before using this product, especially if you are taking any prescription, over the counter medication, dietary supplement product, or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes, difficulty urinating due to prostate enlargement or if you are taking a MAOI (Monoamine Oxidase Inhibitor) or any other medication. If taking a blood-thinning medication, consult a healthcare practitioner.

Discontinue use and consult your health care professional if you experience adverse reaction to this product. Discontinue use 2 weeks prior to surgery. Do not exceed recommended serving. Do not use if safety seal is broken or missing.

Keep out of reach of children.

Warning: Consuming this product can expose you to chemicals including lead, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Formulation Notes

Comprehensive support for healthy prostate function

Manufactured in a U.S. cGMP Facility

Metadata

Product Details

UPC / SKU6 58580 070571
DSLD Entry Date2022-07-21
Product TypeOther Combinations
FormCapsule
DSLD ID269439
Data Updated2026-04-11
Research

Research Evidence

5
Research Sources
44
Avg Quality
5
Rct
C A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
Rct Breast cancer research and treatment 2017 PubMed DOI
C Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
Rct European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016 PubMed DOI
C Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women
Rct Nutrition and cancer 2023 PubMed DOI
C The effects of light exposure on the cortisol stress response in human males.
Rct Stress (Amsterdam, Netherlands) PubMed DOI
D Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer
Rct Nutrition and cancer 2004 PubMed
View all evidence for Dim →
Compare

Similar Products

View all Dim products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.